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952 F. Suhr et al.hBMSCs maintain their differentiation potentials after fESW treatment, whereas 0.2 mJ ∗ mm−2 is themost effective application. In
conclusion, our results establish first-timely that hBMSCs' behavior can bemodified and optimized in response to definedmechanical
stimulation. These findings appear particularly promising as they suggest that mechanical stress preconditions hBMSCs for improved
therapeutic performance without genetic manipulations and that mechanically preconditioned hBMSCs will be advantageous for
hBMSC-based tissue regeneration. Therefore, this approach opens the door for exploiting the full potential of these cells in
regenerative medicine.
© 2013 Elsevier B.V. All rights reserved.Introduction
Human bone marrow stromal cells (hBMSCs) are characterized
by their capability to differentiate into various mesenchymal
tissues, including adipocytes, chondrocytes and osteocytes
(Ciapetti et al., 2006; Kuznetsov et al., 1997a; Meinel et al.,
2004; Pittenger et al., 1999; Tondreau et al., 2004). hBMSCs
are a promising tool for the field of regenerative medicine for
several reasons; they can be cultured ex vivo, have endoge-
nous activation potential (Jiang et al., 2002; Pittenger et al.,
1999), can be systemically delivered or undergo allogeneic
transplantation (Krause et al., 2007; Wolf et al., 2009) and
have a high self-renewal potential (English et al., 2010; Kolf et
al., 2007; Nombela-Arrieta et al., 2011; Song et al., 2006;
Zaragosi et al., 2006). Their immunosuppressive properties
make them a promising tool to counter complications arising
from graft versus host rejections in transplantation settings of
cells other than hBMSCs (English et al., 2010; Prockop, 2009).
It should be noted that the transplantations of BMSCs have not
been highly successful, yet, in order to cure disease tissue, as
BMSCs disappear within a short period of time after transplan-
tation. However, a myriad of research is still geared towards
utilizing their differentiation potential for tissue engineer-
ing approaches, particularly for cartilage and bone regen-
eration (Nombela-Arrieta et al., 2011) indicating the unraveled
potential of BMSCs in tissue regeneration.
How hBMSCs exert their beneficial effects in tissue regener-
ation is, however, less clear. It was first hypothesized that
BMSCs engraft directly into the degenerative tissue and
differentiate into the respective cell type (Mahmood et al.,
2003; Murphy et al., 2003). However, there is accumulating
evidence in favor of a second hypothesis postulating that BMSCs
predominantly contribute to tissue regeneration by their
capability to secrete a variety of trophic factors contributing
to paracrine effects in tissue repair (Gnecchi et al., 2005;
Haynesworth et al., 1996; Ladage et al., 2007; Mirotsou et al.,
2007) rather than tissue-specific differentiation (Prockop,
2009). Regardless of how BMSCs unfold their remarkable healing
properties, it has been demonstrated in different studies that
only a low percentage of transplanted hBMSCs reaches the
targeted disease area (Hofmann et al., 2005) and that after a
few days, only a small amount (2–6%) persists in the affected
tissue (Hofmann et al., 2005; Kolf et al., 2007). In addition
to the limitation of the presence of BMSCs at the site of injury,
certain proportions of these cells need to display proliferative
and apoptotic, as well as migratory, behaviors in order to
mediate tissue repair (Li and Jiang, 2011; Schmidt et al.,
2006). Thus, the therapeutic success of using hBMSCs in
tissue regeneration has been limited and falls far behind
their potential.
In order to increase the efficiency of targeting hBMSCs to
the disease area and to promote their beneficial cellularresponse at those desired targets for therapeutic use, novel
strategies avoiding genetic manipulation are needed (Karp
and Leng Teo, 2009; Peterson et al., 2011; Schumann et al.,
2006; Yan et al., 2011) to precondition BMSCs (Ghanem et
al., 2009). Extracorporeal shock waves (ESW) are transient
pressure fluctuations that propagate 3-dimensionally and
that are widely applied in the context of therapeutic
mechanotransduction with a high success of increased tissue
regeneration (Nishida et al., 2004; van der Jagt et al., 2011,
2013). Two major types of ESW are used in medical
therapies, focused and radial ESW, whereas the former
ESW type reflects high-peak pressure amplitudes and the
majority of energy flux is concentrated on a small focus
(Chang et al., 2012). These data show that focused ESW
(fESW) types might be a suitable tool for preconditioning
hBMSCs in order to improve their therapeutic potentials.
It is known that the expression of genes involved in
differentiation pathways of hBMSCs can be influenced by
mechanical stimuli (Friedl et al., 2007). Different groups
have shown that ESW offer great beneficial potential in the
treatment of patients suffering from different conditions,
including injured bone, cartilage and cardiac tissue (Nishida
et al., 2004; Wang et al., 2003). Unfortunately, the
mechanistic foundation for these improvements has not
been addressed in these studies and the identity of cellular
contributors has not been confirmed. In this context, no
knowledge exists concerning the potential effects of ESW
application on cell biological properties of hBMSCs, such as
proliferation and migration, that are crucial for successful
medical BMSC-based therapies (Li and Jiang, 2011). Addi-
tionally, it remains unclear whether hBMSCs maintain their
full differentiation potentials after treatment with mechan-
ical stimuli.
To address the unresolved, but highly significant question
of whether hBMSCs' behavior can be manipulated by ESW
application and whether those manipulations depend on
energy and/or timing of ESW application as well as whether
hBMSCs maintain their full differentiation potentials after
ESW treatment, the present study hypothesized (I) that ESW
applications induce cell biological effects on purified cultured
hBMSCs that prove beneficial for tissue regeneration, (II) that
the cell biological processes are dependent on the dose of ESW
application and (III) that hBMSCs maintain their full differenti-
ation potentials after ESW applications. The results clearly
demonstrate that ESW promote biological processes in hBMSCs,
including increased proliferation, survival and migration,
which are described to prove beneficial for tissue regenera-
tion. Additionally, ESW do not disturb hBMSCs' differentiation
potentials. Therefore, the presented observations demonstrate
that ESW stimulations of a defined nature are a dynamic
approach to manipulate hBMSC behavior in vitro in order to
exploit their full regenerative capacity in vivo. Furthermore,
953Mechanical stimulations regulate hBMSC behaviorthe benefits of ESW application are obtained without any
manipulation prohibitive to immediate therapeutic application.
Materials and methods
hBMSC isolation and culture
Adult hBMSCs were isolated from the bone marrow of human
femoral heads from patients receiving hip joint replace-
ments. The average age of the patients was 73 ± 7.4 years.
Only material that tested negative for HIV and hepatitis was
accepted. After abrading the marrow of the femoral head
and filtering the marrow with PBS up to a volume of 50 mL, a
density gradient centrifugation was performed. The fraction
containing hBMSCswas purified as described recently (Steingen
et al., 2008). Cells were cultured in alpha modifications of
Eagle's Medium (alpha-MEM, PAA with Glutamine, without
Nucleosides, Cölbe, Germany) supplemented with 20% FCS
(Biowest, Nuaille, France). The medium was changed the first
time after two days of culture. The cells were used up to
passage 3 and plated at a density of 2000 cells ∗ cm−2 for
culturing purposes (Schmidt et al., 2006). hBMSCs were
passaged by Accutase™ with an optimal confluence of approx-
imately 80%. The studywas authorized by the ethics commission
of the Medical School of the University Cologne and was in line
with the declaration of Helsinki.
hBMSCs characterization
Briefly, hBMSCs were characterized using FACS analysis as
described by Steingen (2008). Freshly isolated hBMScs were
plated with a density of 1000 cells ∗cm−2 (adipogenic and
osteogenic differentiation) or 2000 cells ∗ cm−2 (chondrogenic
differentiation), respectively, and were characterized using a
colony-forming unit-fibroblast (CFU-F) as described earlier
(Friedenstein et al., 1966, 1976). Thereby, it should be noted
that populations of human marrow CFU-Fs are heterogeneous
with respect to their differentiation capacity (Kuznetsov et al.,
1997b; Sacchetti et al., 2007). The identity of hBMSCs was
confirmed by established methods in our lab culturing
the hBMSCs under conditions favorable for adipogenic [basic
medium: alpha-MEM; 2 mM L-glutamine (Sigma-Aldrich,
Munich, Germany), 60 μM indomethacin (Sigma-Aldrich,
Munich, Germany), 1 μM dexamethasone (Sigma-Aldrich,
Munich, Germany), 0.5% antibiotics-antimycotics (Invitrogen,
Karlsruhe, Germany), 5 μg ∗ mL−1 insulin (Sigma-Aldrich,
Munich, Germany), 15% FCS (Biowest, Nuaille, France)], chon-
drogenic [basic medium: D-MEM; 2 mM L-glutamine (Sigma-
Aldrich, Munich, Germany), 50 μMascorbic acid (Sigma-Aldrich,
Munich, Germany), 10 ng ∗ mL−1 transforming growth factor
beta (Sanver Tech, USA), 0.5 μg ∗ mL−1 insulin (Sigma-Aldrich,
Munich, Germany), 0.5% antibiotics–antimycotics (Invitrogen,
Karlsruhe, Germany), 1% FCS (Biowest, Nuaille, France)] or
osteogenic [basic medium: alpha-MEM; 2 mM L-glutamine
(Sigma-Aldrich, Munich, Germany), 60 μM ascorbic acid
(Sigma-Aldrich, Munich, Germany), 10 mM β-glycerophosphate
(Sigma-Aldrich, Munich, Germany), 0.1 μM dexamethasone
(Sigma-Aldrich, Munich, Germany), 0.5% antibiotics–
antimycotics (Invitrogen, Karlsruhe, Germany), 15% FCS
(Biowest, Nuaille, France)] differentiation (Baumgartner et
al., 2010; Steingen et al., 2008).Adipogenic differentiation of hBMSCs was proven by Oil
Red staining. Osteogenic differentiation of hBMSCs was
proven by von Kossa staining. Chondrogenic differentiation
was either proven by morphological Alcian blue (Okamoto et
al., 2002) or Toluidine blue staining or by RT-PCT (see
Section 2.3). Especially for the proof of maintenance of full
differentiation capacities of hBMSCs after fESW treatment
(see Section 2.4) we used morphological methods rather
than RT-PCR to evaluate both the differentiation indicators
described above and the morphology of hBMSCs. hBMSC
morphology cannot be obtained by RT-PCR; however, the
morphology represents a highly relevant marker in order to
assess the influence of mechanical stimuli on the integrity of
mechanically treated hBMSCs.
Proof of chondrogenic differentiation by RT-PCR
RNA of fESW-treated and -untreated hMSCs was extracted
with the Peq-Gold TriFast reagent (PeqLab, Erlangen,
Germany) according to the manufacturer's protocol. RNA
was incubated with DNase (Invitrogen, Karlsruhe, Germany) for
15 min at room temperature to avoid DNA contamination. 1 μg
RNA was used for RT-PCR. RNA was reverse-transcribed into
cDNA using OmniScript reverse transcriptase kit (Qiagen, CA,
USA) according to themanufacturer's protocol. For PCR, 1 μg of
cDNA template was used, respectively. The following primers
were used to prove for chondrogenic (collagen type II, GenBank
number: NM_001844.4; forward: GAA CAT CAC CTA CCA CTG
CAA G, reverse: GCA GAG TCC TAG AGT GAC TGA G) (Steingen
et al., 2008), β-actin served as internal control, (GenBank
number: NM_001101.3; forward: ACC TTC AAC ACC CCA GCC
ATG TAC G, reverse: CTG ATC CAC ATC TGC TGG AAG GTG G).
Resulting PCR productswere analyzed using gel electrophoresis.
Application of focused and radial extracorporeal
shock waves on hBMSCs
Cultured hBMSCs were subjected to focused (fESW) applica-
tions using the extracorporeal shock wave systemDuolith®SD1
(Storz Medical AG, Trägerwilen, Switzerland) in 100 mm
dishes (ibidi, Martinsried, Germany). fESW modes were
applied to hBMSCs on a heat-stable foil and on an absorbing
support surface (freshly prepared pork skin). In order to mimic
the in vivo situation, culture dishes were filled completely
with media and covered with freshly prepared pork skin
(Fig. 1). For optimal coupling with the Duolith®SD1 system, an
ultrasound gel (Parker Laboratories, Fairfield, NJ, USA) was
placed on top of the pork skin. fESW applications were
conducted as follows: continuous pulse, 1000 impulses, 4 Hz.
Energy densities were as follows: 0 mJ ∗ mm−2 (control),
0.2 mJ ∗ mm−2, and 0.3 mJ ∗ mm−2. To evaluate the growth
rate of hBMSCs before and after fESW applications, the cells
were splitted after either control or after 0.2 mJ ∗ mm−2
application with 2000 cells ∗ cm−2. After 24 h the cell number
was again quantified. Every biological experiment was
performed in quadruplicate and in a single session.
fESW treatments were also applied on cultured hBMSCs in
order to test the influence of fESW on hBMSC differentiation
potentials. Therefore, hBMSCs were treated with fESW as
described above in this section and subsequently differen-
tiated as described in Section 2.1.
Adherent cells
Cell-specific medium
Pork skin
ESW applicator
Figure 1 Cartoon of the experimental setup.
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Prior immunocytochemistry, hBMSCs were fixed with 4%
paraformaldehyde (PFA) for 1 h at room temperature before
histological analysis (Steingen et al., 2008). hBMSC prolifer-
ation was detected by incubation with rabbit polyclonal anti
Ki67 (Scholzen and Gerdes, 2000) antibody (dilution: 1:200,
Abcam, Cambridge, UK) overnight at 4 °C. hBMSC apoptosis
was detected by incubation with rabbit polyclonal anti
caspase-3 (Patel et al., 1996) antibody (dilution: 1:500, BD,
Heidelberg, Germany) overnight at 4 °C. Respective sec-
ondary antibodies (Dako Deutschland GmbH, Hamburg,
Germany) were used with a dilution of 1:400. hBMSCs were
examined with a Zeiss Axiovert 200 M light microscope
coupled to a Axio Cam MR Video Camera (Carl Zeiss, Jena,
Germany). Digitally captured images (200× magnification)
were analyzed by assessment of optical densitometry with
the software ImageJ® (National Institutes of Health, USA).
Negative control hBMSCs were processed as were experi-
mental hMSCs; however, primary antibody incubations were
substituted by incubation with 0.8% TBS.
Analysis of the cytoskeletal morphology
To visualize directed F-actin stress fibers and disorganized
actin fibers of the cytoskeleton, fESW-treated and -untreated
hBMSCs were washed in 0.05 M TBS followed by perme-
abilization with 0.25% Triton X-100, washed again with TBS
and subsequently dyedwith phalloidin/Alexa Fluor488 (dilution
1:40 in TBS, Molecular Probes, Invitrogen, Leiden, Netherland)
for 20 min (Pellegrin and Mellor, 2007; Spallarossa et al., 2010)
and covered with 4,6-diamidino-2-phenyl-indol (DAPI) con-
taining mounting medium (Vectashield, Vector Laborato-
ries). For analysis of directed F-actin stress fibers and
disorganized actin fibers, the total number of DAPI-positive
hBMSCs was quantified using a fluorescence microscope
(Axiovert 200 M, Carl Zeiss, Jena, Germany). Directed
F-actin stress fibers as well as disorganized actin fibers
were related to the total number of DAPI-positive hMSCs.
Additionally, the percentage of disorganized actin fibers of
hBMSCs was documented in fESW-treated -untreatedhBMSCs, indicating structural rearrangements of the cyto-
skeleton (Jaalouk and Lammerding, 2009; Spallarossa et al.,
2010) in response to fESW applications.
Boyden chamber assay
The migration assay was performed in a modified Boyden
chamber assay as described previously (Schmidt et al.,
2006). In brief, after hBMSCs were grown to a confluent
monolayer and the dishes were treated with singular
applications of fESW. Untreated dishes served as controls.
After fESW treatments, hBMSCs were detached by Accutase
and counted. 5 ∗ 104 cells were seeded on top of the specific
migration filter (8 μm pores, Falcon® HTS Fluoro Blok™,
Becton Dickinson Labware Europe, Le Pont De Claix, France)
and were incubated for 8 h at 37 °C, 5% CO2, and 95%
humidity in 20% FCS-containing alpha-MEM in a 24-well plate
(Tissue Culture Plate, Becton Dickinson Labware Europe, Le
Pont De Claix, France). Subsequently, hBMSCs were fixed
using 4% paraformaldehyde (PFA). The cells were covered
using mounting medium containing DAPI (Vectashield,
Vector Laboratories). The number of migrated hBMSCs was
counted and documented using a fluorescent microscope
(Axiovert 200 M, Carl Zeiss Microscopy, Jena, Germany).
Only completely migrated cells were taken into account for
further analysis.
Wound healing and scratch assay of hMSCs
In vitro wound healing assays (scratch assays) were performed
as described previously (Faber-Elman et al., 1996). After fESW
application, the treated hBMSCs were incubated for 24 h in
the Axiovert 200 M light microscope (Carl Zeiss, Jena,
Germany) under cell culture conditions (37 °C, 5% CO2, and
95% humidity) in 20% FCS-containing alpha-MEM. Time lapse
video analysis was used to document the wound healing
process; every 10 min pictures were taken with a 5× objective
(A-Plan 5×/0.12, Carl Zeiss, Jena, Germany). The wound area
was calculated with the Axiovision software (Carl Zeiss, Jena,
Germany).
Cell tracking assay of hMSCs
To monitor cell movements, cell tracking analysis of hBMSCs
in response to fESW applications was performed as described
(Schmidt et al., 2006). In brief, hBMSCs were plated at a
density of 2000 cells ∗ cm−2 on cell culture dishes (Ibidi,
Martinsried, Germany). ESW-treated and untreated control
hBMSCs were monitored by time lapse video for 24 h until
hBMSCs reached a confluence of about 40%. During that
time, the cells were incubated for 24 h in the Axiovert 200 M
light microscope (Carl Zeiss, Jena, Germany) under cell
culture conditions (37 °C, 5% CO2, and 95% humidity) in 20%
FCS-containing alpha-MEM. Every 10 min, pictures were
taken with a 5× objective (A-Plan 5×/0.12, Carl Zeiss,
Jena, Germany); data were exported to Metamorph micros-
copy analysis software (Molecular Devices, Sunnyvale, CA,
USA) for further analysis. The analyzed parameter included
the velocity of hBMSCs, their distance [pixel] per 10 min and
their total distance to the starting point after 24 h.
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One-way analysis of variances (ANOVA) of each fESW condition
was performed using Statistica software package (Statistica
for Windows 7.0, Tulsa, USA). If the one-way ANOVA was
significant, individual differences between tested conditions
were tested by applying a post hoc test (Duncan's multiple
comparison test). Statistical significance was considered for
p b 0.05. A paired Student's t-test was applied to test the
applied stimulus of 0.2 mJ ∗ mm−2 compared to control
condition on hBMSC growth rate and wound healing/scratch
assay. Statistical significance was considered for p b 0.05.
Data are presented as mean ± standard error of means
(S.E.M.).
Results
The present study examined dose-dependent modifications
of fESW-generated mechanical stimuli on cellular behaviors
of hBMSCs. The focus of the present study was on the cell
biological effects, such as proliferation, apoptosis, growth
rate, actin cytoskeletal rearrangements and cell migration
properties of fESW treatments. Additionally, we studied the
differentiation potential of fESW-treated hBMSCs compared
to untreated hBMSCs.
Characterization of hBMSCs
As hBMSCs are a rare population within the human bone
marrow, we sought to rigorously enrich cell preparations for
true hBMSCs in terms of representative surface markers using
FACS (Baumgartner et al., 2010; Pittenger et al., 1999; Steingen
et al., 2008). Subsequently, the identity of hBMSC preparations
was confirmed by different means. fESW-untreated hBMSCs
were characterized by adipogenic, chondrogenic and osteo-
genic differentiation assays (Figs. 2A,B). Fig. 2A shows
fESW-untreated hBMSC morphology at different confluence
levels (Figs. 2A1, A2) as well as adipogenic (Fig. 2A3, control
Fig. 2A4), osteogenic (Fig. 2A5, control Fig. 2A6), and
chondrogenic (Fig. 2A7, control Fig. 2A8) differentiation
assays. Additionally, the chondrogenic differentiation capac-
ity of fESW-untreated hBMSCs was confirmed by RT-PCR
(Fig. 2B).
As the growth rate depends on cell proliferation and apop-
tosis (Klotz et al., 2012), we next aimed to quantify the effects
of different fESW applications on these cellular processes by
investigatingmarkers of proliferation and activated apoptosis in
hBMSCs in more detail.
Proliferation and apoptosis of hBMSCs in response to
fESW applications of different intensities
To determine the effects of fESW application on hBMSC
proliferation and apoptosis, hBMSCs were immunohisto-
chemically stained for Ki67 and caspase-3, respectively.
Ki67 represents a common proliferation marker and is
expressed in all active phases of the cell cycle, except the
G0 phase (Heidebrecht et al., 1996; Traut et al., 1998).
hBMSCs were stained 6 h and 12 h after fESW applications.
Compared to the control conditions, application of fESW(0.2 mJ ∗ mm−2) resulted in a significant increase in prolif-
erative hBMSCs after both 6 h (p b 0.01) and 12 h (p b 0.05)
(Fig. 3A). Application of 0.3 mJ ∗ mm−2 showed no effects
after 6 h (p N 0.05), but a significant decrease of prolifer-
ative hBMSCs after 12 h (p b 0.01) (Fig. 3A) compared to
control hBMSCs.
Activation of apoptosis of hBMSCs after fESW treatments
was investigated using the marker caspase-3 (Patel et al.,
1996). hBMSCs were stained 6 h and 12 h after fESW
applications. Compared to control conditions, the application
of fESW (0.2 mJ ∗ mm−2) resulted in a significant increase in
apoptotically activated hBMSCs after 6 h (p b 0.05) (Fig. 3B).
However, this effect was transient as after 12 h, the number
of caspase-3 positive cells decreased even below control
levels, although this difference was not significant (Fig. 3B).
Application of 0.3 mJ ∗ mm−2 resulted in a significant increase
in apoptotically activated hBMSCs after both 6 h (p b 0.01)
and 12 h (p b 0.01) (Fig. 3B). In summary, these results show
that proliferation and apoptosis are influenced by fESW-
induced mechanical stimulation in hBMSCs. Importantly, both
parameters can significantly be influenced by fESW applica-
tions in a dose-dependent manner. Of all conditions tested,
the fESW with an intensity of 0.2 mJ ∗ mm−2 was found to be
an optimal stimulation, combining maximal induction of
proliferation with minimal activation of apoptosis.Determination of growth rate of hBMSCs in response
to fESW applications
hBMSC growth rates of were determined in order to qualita-
tively characterize hBMSCs in culture (Arnhold et al., 2006) as
well as to examine the effects of fESW (0.2 mJ ∗ mm−2
applications). The growth rate (W = dN ∗ dt−1) describes the
reproduction of hBMSCs per time unit, in our case within 24 h.
The proliferation potential of control samples strongly
suggests that the start material contained highly enriched
hBMSCs. As the fESW (0.2 mJ ∗ mm−2) led to the highest
increase of hBMSC proliferation and even reduced activation
of apoptosis, we focused on this stimulation. fESW applications
were observed to significantly (p b 0.01) stimulate hBMSC
reproduction (around 1.25 ∗ 105 cells ∗ 24 h−1, Fig. 3C), which
support our findings of increased proliferation and decreased
apoptotically activated hBMSCs. These results indicate impor-
tant regulatory influences of fESW-induced mechanical stimu-
lations on growth rates of hBMSCs and the increased cell
number is in line with other studies (Higuera et al., 2009). To
further determine cell biological characteristics of untreated
compared to fESW-treated hBMSCs, we next aimed to quantify
the effects of shock wave-induced mechanical stimuli on
migration properties of hBMSCs in more detail.Boyden chamber assay
The migratory behavior of hBMSCs is known to be critical for
their successful application in tissue regeneration (Li and
Jiang, 2011). Migratory properties of hBMSCs after fESW
applications were assessed by the use of a modified Boyden
chamber assay (Schmidt et al., 2006). Migrated hBMSCs were
assessed in a meander-shaped manner to avoid duplicate
determinations.
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Figure 2 hBMSC characterization. (A) Morphological and biochemical approaches for characterizing hBMSCs. (A1, A2) Undifferentiated
hBMSCs grown in monolayer culture shown at different confluence levels. A1 shows hBMSCs at a confluence of about 40%; A2 shows
hBMSCs at a confluence of about 85%. (A3, A4) Adipogenic differentiation of hMSCs. A3 depicts RedOil staining of lipid vacuoles after three
weeks of adipogenic stimulation; A4 shows control hBMSCs stained with hematoxylin/eosin. (A5, A6) Osteogenic differentiation of
hBMSCs. A5 shows von Kossa staining of calcium deposits after three weeks of osteogenic stimulation; A6 shows control hBMSCs stained
with nuclear fast red-aluminum sulfate solution. (A7, A8) Chondrogenic differentiation of hBMSCs. A7 shows Toluidine blue staining after
threeweeks of chondrogenic stimulation; A8 shows control hBMSCs. (B) Chondrogenic differentiation (D) of hBMSCs proven by RT-PCR, but
not in the proliferation approach (P). H2O was used as a negative control. Actin served as an internal housekeeping gene and showed no
regulation by either D or P approaches. No signal was observed in the H2O control.
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**p b 0.01.
957Mechanical stimulations regulate hBMSC behavior
958 F. Suhr et al.fESW applications (0.2 mJ ∗ mm−2) resulted in signifi-
cantly increased numbers (p b 0.05, Fig. 4A) of completely
migrated hBMSCs, whereas application of 0.3 mJ ∗ mm−2
inhibited the migration of hBMSCs significantly (p b 0.05,
Fig. 4A). These results demonstrate the existence of a
physiological threshold above which mechanical stimulations
seem to be counterproductive for the induction of hBMSC
migration. Therefore, fESW-induced mechanical stimula-
tions induce dose-dependent biological effects on hBMSCs.
Actin cytoskeleton arrangement of hBMSCs
In hBMSCs F-actin is well-organized in linear stress fibers
(Fig. 4B). Cytoskeletal architecture, such as directed F-actin
stress fibers, is known to be crucial for cell migration
(Pellegrin and Mellor, 2007). Therefore, it was tested
whether mechanical stimuli can modify the actin cytoskele-
ton. Fluorescence-labeled phalloidin (Alexa Fluor488) was
used to visualize the F-actin cytoskeleton of hBMSCs (Pellegrin
andMellor, 2007; Spallarossa et al., 2010). hBMSC cytoskeletal
organization was determined 0 min and 30 min after fESW
applications.
fESW (0.2 mJ ∗ mm−2 and 0.3 mJ ∗ mm−2) treatments
resulted in an initially significantly (p b 0.05) decreased
portions of directed F-actin fibers. However, 30 min after
0.2 mJ ∗ mm−2 application the cells recovered and presented
with a massive assembly of directed F-actin fibers (p b 0.05)
(Fig. 4B), while the cells were only able to reassemble very
few fibers within 30 min post 0.3 mJ ∗ mm−2 treatment
(Fig. 4B).
These results suggest that the stimulation with fESW
(0.2 mJ ∗ mm−2) might prove optimal to induce migration of
hBMSCs. We tested this assumption directly using different
assays.
Disorganized and partly destroyed actin fibers indicate
rearrangements of the cellular cytoskeleton (Morita et al.,
1994; Spallarossa et al., 2010). Therefore, the portion of
disorganized actin fibers was also quantified in response to fESW
applications 0 min and 30 min after treatment. Compared to
the control condition, fESW treatment (0.2 mJ ∗ mm−2 and
0.3 mJ ∗ mm−2) resulted in a significantly (p b 0.05 for each)
increased portion of disorganized actin fibers in hBMSCs at
0 min post-treatment (Fig. 4C). A similar picture was observed
at 30 min (p b 0.05), but only after 0.3 mJ ∗ mm−2 fESW
application (Fig. 4C). In contrast, but in line with the directed
F-actin fibers (Fig. 4B), 0.2 mJ ∗ mm−2 significantly (p b 0.01)
reduced disorganized actin fibers at 30 min post-treatment
(Fig. 4C). These results indicate important divergent influences
of fESW application in a dose-dependent manner and indicate
0.2 mJ ∗ mm−2 as most beneficial for directed F-actin
assembly.
Cell tracking assay
To assess hBMSC movements, cell-tracking assays were
performed. fESW-treated and -untreated hBMSCs were
photographed every 10 min over a time course of 24 h to
document hBMSC movement in response to fESW applica-
tions. The treatment of hBMSCs with any fESW condition
resulted in comparable significant increases in movement
velocities of hBMSCs compared to control hBMSCs (p b 0.05,Fig. 5, see also video data 1 and 2 in the supplementary
data). These results lead to the assumption that mechanical
stimulations exerted by fESW of divergent intensities posi-
tively influence migration and distance velocities of hBMSCs.
This observation might be of great impact for medical
therapies as hBMSCs often show low infiltrations into diseased
tissues (Hofmann et al., 2005).
Wound healing assay
Due to the results obtained from the Boyden chamber assays,
which indicated a positive influence of fESW (0.2 mJ ∗ mm−2)
applications on hBMSC migration, wound-healing assays were
conducted with hBMSCs using the same treatment. These
assays test whether the increased cell movements are
directed or whether the mechanical stimulation causes
random movements leaving the cells incapable of directed
migration. In this system only directed migration results in a
more efficient wound closure. In comparison to the control
conditions, fESW application of 0.2 mJ ∗ mm−2 resulted in an
increased portion of wound closure at both 4 h (p b 0.05) and
8 h (p b 0.01) post fESW treatment (Fig. 5B, see also video
data 3 and 4 in the supplementary data). Consequently, the
time required to complete wound closure was significantly
decreased (p b 0.05, Fig. 5C). These observations clearly
illustrate that ESW-induced mechanical stimulations have a
positive influence on the movement and velocity of directed
hBMSC migration, demonstrating the potential of mechanical
stimulations for clinical hMSC applications.
hBMSC differentiation potential into adipocytes,
chondrocytes, and osteocytes after fESW treatment
After investigating cell biological behaviors of hBMSCs in
response to fESW treatment we sought to study whether the
differentiation potential of mechanically treated hBMSCs
were still viable and whether the differentiation potential
correlated in a certain manner to the cell biological results
we obtained from our assays. Therefore, hBMSCs were
subjected to both 0.2 mJ ∗ mm−2 and 0.3 mJ ∗ mm−2 fESW
treatments and differentiated into adipogenic, chondrogenic,
and osetogenic cells, whereas fESW-treated hBMSCs were
compared to mechanically untreated hBMSCs (Fig. 6). As
shown in Fig. 6, both fESW treatments directed hBMSCs into
the three lineages as also observed under control conditions.
This is of paramount interest, because mechanically treated
hBMSCs do not lose their differentiation potentials, but remain
able to differentiate into adipocytes, chondrocytes, and
osteocytes. While the adipogenic differentiation was unaf-
fected by fESW treatments (Figs. 6A–C), we observed some
minor, but notable differences between the fESW treatment
conditions during osteogenic and chondrogenic differentia-
tions. Compared to control (Fig. 6D) and 0.2 mJ ∗ mm−2
(Fig. 6E), the osteogenic differentiation potential was slightly
reduced after 0.3 mJ ∗ mm−2 application (Fig. 6F, dashed
arrows). Furthermore, compared to control (Fig. 6 G, arrows)
and 0.3 mJ ∗ mm−2 (Fig. 6I, arrows) conditions we observed
an altered chondrogenic differentiation potential after
0.2 mJ ∗ mm−2 treatment (Fig. 6 H, arrow heads). In the
0.2 mJ ∗ mm−2 condition the chondrogenic cells seem to be
more organized and aligned compared to the control and
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Figure 4 hBMSC migration, directed F-actin, and disorganized F-actin. (A) hBMSC migration behavior was observed by Boyden chamber
assays. The diagram shows that only the fESW (0.2 mJ ∗ mm−2) treatment resulted in an increased number of migrated hBMSCs. The
pictures in the right panel show DAPI positive hBMSCs transmigrated through the 8 μm pore. Control and fESW treatments (0.2 mJ ∗ mm−2
and 0.3 mJ ∗ mm−2) are shown. (B) The diagram shows directed F-actin fibers in response to fESW treatment. As depicted, only the
0.2 mJ ∗ mm−2 treatment resulted in an increased percentage of directed F-actin fibers in hBMSCs compared to control hBMSCs. The
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960 F. Suhr et al.0.3 mJ ∗ mm−2 conditions, indicating a more effective
chondrogenic differentiation after 0.2 mJ ∗ mm−2 application
compared to controls and 0.3 mJ ∗ mm−2. Similarly, we
observed this phenomenon also by means of the second
chondrogenic evidence, Toluidine blue (Fig. 6 K, arrow heads)
when compared to control (Fig. 6J) and 0.3 mJ ∗ mm−2
(Fig. 6 L). These data indicate that hBMSCs maintain their
full differentiation potentials even after fESW treatments,Contro
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Awhile minor, but relevant differences can be observed proving
that 0.2 mJ ∗ mm−2 energy density seems to be the most
beneficial application. These data confirm that 0.2 mJ ∗ mm−2
might prove optimal for hBMSCs preconditioning, as suggested
by the data shown above.Discussion
While the potential usefulness of hBMSCs in regenerative
medicine is undisputed, the efficacy of hBMSC-based treat-
ments appears to decisively depend upon how effectively
transplanted hBMSCs can be targeted persistently to the
diseased area and how functional these cells are in terms of
the regeneration process. We hypothesized in the present
study that fESWmodify cell biological behavior of hBMSCs and
further, that this allows for mechanical priming of hBMSCs in
order to improve their biological properties important for
tissue regeneration (Ingber, 2006). fESW have been shown to
be a source of mechanical impacts and have been used
successfully in regenerative cardiac medicine (Nishida et al.,
2004). Additionally, a recent study proposed positive effects
of ESW applications in bone marrow-derived endothelial
progenitors to improve ischemic areas in rodent critical limb
ischemia (Yeh et al., 2012), demonstrating the significance
of ESW also in other tissues. However, in these studies the
mechanistic basis or possible cellular players were not
explored.
In hBMSC-based cell therapy, the number of cells present
in the target tissue can be increased either by upscaling the
total amount of transplanted cells or by repeated delivery.
A myriad of studies has used different approaches, including
genetic manipulation, to control the behavior of hBMSCs;
however, thus far, no approach has proved to be therapeu-
tically feasible. We hypothesized that fESW applications
would stimulate hBMSC expansion without the need for
genetic manipulation, making this approach directly com-
patible with clinical use.
To quantify the proliferative stimulation of fESW applica-
tions in hBMSCs, the proliferationmarker Ki67 (Heidebrecht et
al., 1996; Traut et al., 1998) was used. We observed that fESW
application results in proliferation rates about 75% greater
than those of untreated cells, which is much higher than the
20–60% increase described in previous mechanical stimulation
studies (Arnhold et al., 2006; Schmidt et al., 2006). Addition-
ally, we found the proliferative effect to last nearly 12 h postFigure 5 Cell tracking assay and wound healing/scratch assay.
(A) The diagram shows that applications of different fESW
treatments result in significantly increased migration velocities of
fESW-treated hBMSCs compared to untreated control. See also
video data 1 and 2 (supplementary data). (B) The diagram shows the
percentage of wound closure by fESW-treated (0.2 mJ ∗ mm−2)
hBMSCs 4 and 8 h post-treatments. fESW treatment of hBMSCs
results in significantly increased percentage of wound closure at
both investigated time points compared to the respective control
situations. See also video data 3 and 4 (supplementary data).
(C) The diagram shows that the time needed for a complete wound
closure was significantly reduced after fESW (0.2 mJ ∗ mm−2)
treatment compared to untreated control hBMSCs. *p b 0.05,
**p b 0.01.
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961Mechanical stimulations regulate hBMSC behaviorfESW treatment, exceeding the effects of mechanical stimu-
lations previously described.
It has been demonstrated that mechanical impacts can
induce apoptosis in various cells including cancer cells (Kato
et al., 2000; Kearney et al., 2008). In the present study, we
found that this observation holds true for hBMSCs; however,
the intensity of the mechanical stimulation appears to be of
central importance. After an initial increase, the apoptosis
rate of cells 12 h after application with 0.2 mJ ∗ mm−2 fESW
was significantly reduced compared to control levels.
Combined, these data demonstrate that fESW-induced
mechanical stimulations result in increased hBMSC growth
rates. As it was demonstrated recently that different culture
media exert different effects of hBMSC growth rates (Ben et
al., 2012), we speculate that improved culture conditions,
combined with the right choice of mechanical stimulations,
will provide the best outcomes for hBMSC expansion.
Directed stress fibers were shown to increase cell
migration (Kreis and Birchmeier, 1980; Spallarossa et al.,
2010) and determine the migration direction (Rid et al.,2005). Our experiments demonstrate that the fESW-induced
mechanical stimulations result in significant increases in
hBMSC F-actin stress fiber formation and migration, indicat-
ing a positive cell biological effect of the applied stimuli on
these cells in a dose-dependent manner. More precisely,
fESW applications resulted in a significant reduction of
directed F-actin fibers, with the exception of 0.2 mJ ∗ mm−2
at 30 min post-treatment. Therefore, the formation of F-actin
stress fibers in hBMSCs strongly depends on the applied stress
dose.
Disorganized actin fibers can limit cell migration (Spallarossa
et al., 2010). The formation of disorganized actin fibers
indicates a rearrangement of the cytoskeleton and, there-
fore, can be independent of directed F-actin stress fibers
(Jaalouk and Lammerding, 2009). As demonstrated, fESW
applications resulted in increased disorganized actin fibers
after treatment along with a massively increased portion of
directed F-actin fibers concurring with a low formation of
disorganized actin fibers post-intervention. Both events
might contribute synergistically to the improved migratory
962 F. Suhr et al.properties of preconditioned hBMSCs. In summary, our results
show that applications ofmechanical impacts induced by fESW
might particularly improve BMSC migration.
As it was reported previously that mechanical stimuli
cannot increase the migration of hBMSCs (Ode et al., 2011)
we tested this in detail using three different assay systems.
All of our experiments clearly showed that application of
fESW results in increased hBMSC migration. However, the
results of these respective studies are difficult to compare as
the source of mechanical stimulation differed and the
differently applied energy densities could possibly explain
the discrepancies. Particularly, our data show that the nature
and intensity of mechanical stimulation are of key importance
for the cellular response. Future investigations should care-
fully address the migration behavior of hBMSCs in response to
definedmechanical treatments; we have strong evidence that
this kind of hBMSC preconditioning is a particularly promising
approach to improve hBMSC-based therapies. In this context,
also less specified cells, such as fibroblasts or muscle cells,
should be investigated, because it is reasonable that these
cells might also react in a comparablemanner, as they are also
mechano-sensitive.
Additionally, Schmidt et al. (2006) demonstrated a positive
influence of bFGF on the wound healing ability of hBMSCs.
Therefore, we propose that a combined treatment with both
growth factors and mechanical stimulations could further
improve the tissue regenerative capacities of hBMSCs. Alter-
natively, it would be interesting to test whether mechanical
stimulation leads to secretion of bFGF and/or other growth or
trophic factors that could act in an autocrine fashion andmight
be mechanistically responsible for the effects observed here.
It is interesting that the stimulation with fESW
(0.2 mJ ∗ mm−2) had optimal effects on BMSCs' biological
parameters in our experimental setup. The fact that
mechanical shockwaves fESW have been beneficial to the
healing process in in vivo experiments in combination with
our data suggests that BMSCs are actively involved in the
biological processes leading to functional improvements.
As this has previously been assumed but not demonstrated
(Nishida et al., 2004), our data provide the rationale for the
in vivo use of mechanical stimulation for hBMSC-based
treatments.
This rational is further strengthened by our finding that
the differentiation potentials of hBMSCs remains fully
preserved after fESW treatments compared to untreated
control conditions. These paramount data also explain
finding from the literature that ESW treatment beneficially
induces de novo bone formation in vivo (van der Jagt et al.,
2011; van der Jagt et al., 2013). However, the energy
density seems to be the limiting factor. As discussed above,
we suggest that 0.2 mJ ∗ mm−2 is the most beneficial
stimulus in our setup for priming of hBMSCs. This hypothesis is
also supported by the finding that hBMSCs show best differen-
tiation characteristics following treatment with 0.2 mJ ∗ mm−2
when compared to control and 0.3 mJ ∗ mm−2 conditions.
It will be interesting for future studies to investigate
effects of fESW, but also radial ESW as another ESW source,
on other cell types, e.g. cardiomyocytes or skeletal muscle
precursors in order to evaluate ESW effects on these
important adult cell types. However, the optimal energy
density is likely to differ between different experimental
setups and of course between patients in medical therapyapplications, why special caution has to be put on this issue
in future studies. Together, due to optimal effects of the
same stimulation for multiple aspects of hBMSC behavior and
the unproblematic use of this technique in a clinical setting,
fESW-mediated preconditioning of hBMSCs presents an
elegant tool in regenerative medicine.5. Conclusion
The presented data describe fESW as a potential approach to
manipulate hBMSC behavior for clinical applications. This
approach appears particularly promising as it suggests that
mechanical stress preconditions hBMSCs for improved thera-
peutic performance without any genetic manipulation or loss
of differentiation potential. Because of the high potential of
the present findings to benefit the healing process of adult
degenerative tissue, it is currently tested whether they can be
validated in vivo.
Additionally, our study defines a working intensity and
nature of fESW-derived mechanical stimuli resulting in
improved BMSC behavior, whereby the optimal intensity
and application time will differ dependent of the experi-
mental setup, the patient, and importantly, the used ESW
device. This report identifies how hBMSCs change prolifer-
ation, migration, survival and, in combination with the work
of others, also paracrine activity (Gnecchi et al., 2005) and
proteolytic activity in response to mechanical stress (Kasper
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